Skip to main content
BHI in the News

Tasly Pharmaceuticals Inc. and BHI organize and host first Tasly BioTech/BioPharma CEO Gathering in Rockville

By September 11, 2014No Comments

tasly-bhiTasly Pharmaceuticals, Inc (Tasly) and BioHealth Innovation (BHI) co-organized the first Tasly Meeting of CEOs on Tuesday, September 2, 2014 at the Tasly facility in Rockville. Attendees included more than 25 CEOs and company representatives from local Maryland-based BioTech and BioPharma companies. This was the first public event conducted through Tasly and BHI’s newly initiated partnership.

Tasly is an innovation-based, high-tech healthcare and pharmaceutical enterprise and world-leader in the research and product development (R&D) of Chinese herbal medicine – the leader in the natural way to modernize medicine, with a North American headquarters in Rockville, Maryland, . Tasly and BHI have a formalized partnership which aims to co- organize and coordinate joint BioHealth associated events to promote professional networking, business growth, and technology and product commercialization.

For Tuesday’s event, BHI developed a list of meeting attendees and Tasly hosted the event. Dr. Henry Sun, CEO of the Tasly Pharmaceuticals Inc., kicked off the event by welcoming attendees and introducing Tasly; Mr. Richard Bendis, CEO of BHI, and Ms. Lily Qi, Director of the Special Programs for Montgomery County’s Office of the County Executive , delivered opening remarks. Dr. Xijun Yan, Founder and Chairman of Tasly Holding Groups, of Tianjin, China, provided his vision related to Tasly’s presence in the United States as well as future plans for business development. Dr. Yan expressed an interest in future Tasly collaboration to promote new technologies and add new products to its portfolio.

Tasly Pharmaceuticals, Inc. is located at 9400 Key West Avenue, Rockville, MD, 20850. More information can be found on the company’s website: www.taslyus.com. You may also contact Dr. Shengting Li, Director, Department of Clinical Research, Tasly Pharmaceuticals Inc. at: shengtingli@tasly.com or at: 301-978-3891. For business development, you may contact with Mr. Frederick Ahlers, Manager, Department of Business Development, at fahlers@tasly.com.

tasly-1tasly-2tasly-3tasly-4

 

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.